Cite
HARVARD Citation
Verly, I. et al. (2018). 3-Methoxytyramine: An independent prognostic biomarker that associates with high-risk disease and poor clinical outcome in neuroblastoma patients. European journal of cancer. pp. 102-110. [Online].